As of 2026-03-08, the Relative Valuation of Adverum Biotechnologies Inc (ADVM) is (85.05) USD. This relative valuation is based on P/E multiples. With the latest stock price at 4.36 USD, the upside of Adverum Biotechnologies Inc based on Relative Valuation is -2050.7%.
The range of the Relative Valuation is (76.55) - (90.19) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 19.1x - 23.9x | 21.0x |
| Forward P/E multiples | 18.2x - 22.5x | 21.4x |
| Fair Price | (76.55) - (90.19) | (85.05) |
| Upside | -1855.7% - -2168.5% | -2050.7% |
| Date | P/E |
| 2025-12-08 | -1.09 |
| 2025-12-05 | -1.06 |